A Critical Review of Aspirin in the Secondary Prevention of Noncardioembolic Ischaemic Stroke
- 6 July 2010
- journal article
- review article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 5 (4) , 306-318
Abstract
Both secondary prevention (such as lifestyle modifications, pharmacotherapy or surgery) and an understanding of the influence of risk factors (including the different aetiologic mechanisms of cerebral ischaemia) play a pivotal role in reducing the burden of recurrent stroke. Regarding the types of preventative treatments available, variations exist across all clinical studies, including differences in target populations (including the type of cerebral ischaemia), risk factors, length of follow-up, drop-out rates and outcomes, which makes translating the results of clinical trials to individual patients difficult. However, with such limitations in mind, this critical albeit nonsystematic review, which compared aspirin with other antiplatelets and in combination with other drugs, showed that the benefit from aspirin treatment is consistently shown in ischaemic stroke, while harms are limited. Furthermore, no definite superiority is apparent across different antiplatelet therapies. Dual antiplatelet regimens may expose to a slight but measurable higher risk of haemorrhagic complications, perhaps in selective groups of patients (i.e. those with severe small-vessel disease or in selective racial groups). Based on our analysis, the indication of aspirin as the first-line choice, also recommended by several acknowledged international or national guidelines, may be confirmed. However, the complex nature of patients at risk of recurrent ischaemic stroke necessitates a comprehensive approach, which should be driven by the primary care physician, whose role is central to successful actions for secondary stroke prevention.Keywords
This publication has 63 references indexed in Scilit:
- Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled studyThe Lancet Neurology, 2008
- Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIAStroke, 2008
- Racial Disparities in Stroke Risk FactorsStroke, 2005
- Differences in Vascular Risk Factors Between Etiological Subtypes of Ischemic StrokeStroke, 2003
- Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.Stroke, 1994
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Danish very-low-dose aspirin after carotid endarterectomy trial.Stroke, 1988
- The association between urinary sodium excretion and blood pressure in children.Circulation, 1980
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977